Drugmakers Under More Scrutiny on Capitol Hill
WSJ What’s News - En podkast av The Wall Street Journal
A.M. Edition for February 27th: Major drug makers are facing more scrutiny from lawmakers over pricing. And while big drug companies may have survived a hearing on Tuesday, WSJ Heard on the Street Columnist Charley Grant says the industry is still under the microscope.
Learn more about your ad choices. Visit megaphone.fm/adchoices
